Voxmind | $735,203 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)
XCENA | $135,000,000 | (Jun 2, 2026)
Certified by Founder
Lodge
Alida Biosciences
start up
United States
- San Diego
- 13/06/2024
- Series A
- $7,500,000
Alida Biosciences is developing the next generation of RNA analysis tools to enable new medical treatments and diagnostic assays.
- Industry Biotechnology Research
- Website https://alidabio.com/
- LinkedIn https://www.linkedin.com/company/alida-biosciences/
Related People
Gudrun StengelFounder
United States -
San Diego, California
Strategic leader and product developer with track record in the commercialization of assays, reagents and integrated platforms for biomedical applications. Specialized in -omics applications.
Inherent | $50,000,000 | (Jun 2, 2026)
Gray Swan | $40,000,000 | (Jun 2, 2026)
Handshake(UK) | $3,200,000 | (Jun 2, 2026)
Sekai(US) | $26,000,000 | (Jun 2, 2026)
Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
Perceptic | $12,000,000 | (Jun 2, 2026)
SpeedLabs | $6,500,000 | (Jun 2, 2026)
MokN | $15,000,000 | (May 29, 2026)
Orebella | Undisclosed Amount | (May 29, 2026)